Forecasting

FORECASTING

Market Forecasting

Thelansis has strong expertise in building patient-based market forecasting model which enables our stakeholders in understanding the current epidemiology scenario, potential patient pool, Market Analog, Product attribute, market uptake, patient share uptake, the annual cost of therapy, current drug utilization, prescription share, current clinical practice, and future treatment paradigm. Thelansis with a strong repository of 6,000+ Bio-pharma reports involving 1 Million man-hours catering to the top pharmaceuticals and biotech companies across the mature and emerging markets like USA, Germany, France, Italy, Spain, UK, Japan, China, Singapore, India, Australia, New Zealand, Canada, KSA (Saudi Arabia) and UAE (United Arab Emirates), Brazil, Argentina, and Mexico.

Epidemiology

Epidemiology is the study to understand the distribution of diseases & other health-related conditions within defined population group. The purpose is to understand what risk factors are associated with a specific disease, & how disease can be prevented in groups of individuals; due to the observational nature of epidemiology, it cannot provide answers as to what caused a disease to a specific individual with similar or different comorbidity conditions.

The significance of any Epidemiology study is to estimate the frequency of a disease, to find the potential causes of a disease, to understand the disease progression & stages, to validate the clinical characteristics of the disease condition. To achieve these goals, measures of disease such as, incidence,  prevalence, diagnosed, treated & death (mortality) are made within population groups.

  • Population
  • Diagnosis
  • Treatment

Attribute Analysis

Determine the relative importance of different scientific and commercial indicators of an asset under development. Measure and comparing the scientific indicators such as study endpoints, clinical outcomes and potential of the asset in the future treatment paradigm. Construct a simulation model to determine the optimum treatment attributes and the significance comparing to the current available standard of care. Using the simulation model predict market share among specialists for a drug with differing levels.

dashboard

Analogue Analysis

During New product launching, it is critical to predict adoption as early and precisely as possible for demand planning as well as promotional resource allocation. Analogue analysis is a tool/ technique where probable adoption curve for a pipeline asset to be determine. Our in-house Dynamic Patient-Share tool, which allows predicting the up-take in a very accurate and simple way. Selecting the correct analogue and determining the patient flow/ patient share becomes effortless.

circular_pie_chart_data_up_down-1

Disease Burden Analysis

Disease burden Analysis is the most comprehensive analysis where the mortality and morbidity and risk factors of any disease to analyze at national and regional levels and translated into overall cost burden on each single patient level. Examining trends based on historical and current data sets and making comparisons across populations to understand the changing health challenges.

covid

Cost Effectiveness Modelling

The cost effectiveness modelling starts with the evaluation efficacy, safety, and quality of a product to be justified with respect to the cost. The cost of any therapy is not only consolidation overheads such as development cost, procurement cost, manufacturing cost, marketing and distribution cost but also the cost impact on the entire health care system including the patient.

animated-analytics

Market Forecasting

Thelansis has strong expertise in building patient-based market forecasting model which enables our stakeholders in understanding the current epidemiology scenario, potential patient pool, Market Analog, Product attribute, market uptake, patient share uptake, the annual cost of therapy, current drug utilization, prescription share, current clinical practice, and future treatment paradigm. Thelansis with a strong repository of 6,000+ Bio-pharma reports involving 1Million man-hours catering to the top pharmaceuticals and biotech companies across the mature and emerging markets like USA, Germany, France, Italy, Spain, UK, Japan, China, Singapore, India, Australia, New Zealand, Canada, KSA (Saudi Arabia) and UAE (United Arab Emirates), Brazil, Argentina, and Mexico.